Depreciation, Depletion and Amortization of TREACE MEDICAL CONCEPTS, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary: TREACE MEDICAL CONCEPTS, INC. annual and quarterly Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
TREACE MEDICAL CONCEPTS, INC. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $2,461,000, a 29% increase year-over-year.
TREACE MEDICAL CONCEPTS, INC. annual Depreciation, Depletion and Amortization for 2025 was $10,623,000, a 26% increase from 2024.
TREACE MEDICAL CONCEPTS, INC. annual Depreciation, Depletion and Amortization for 2024 was $8,419,000, a 57% increase from 2023.
TREACE MEDICAL CONCEPTS, INC. annual Depreciation, Depletion and Amortization for 2023 was $5,352,000, a 151% increase from 2022.
Source SEC data: View on sec.gov

Depreciation, Depletion and Amortization, Annual (USD)

Depreciation, Depletion and Amortization, YoY Annual Change (%)

Depreciation, Depletion and Amortization, Trailing 12 Months (USD)

Depreciation, Depletion and Amortization, Quarterly (USD)

Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

TREACE MEDICAL CONCEPTS, INC. Annual Depreciation, Depletion and Amortization (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	$10,623,000	+$2,204,000	+26%	01 Jan 2025	31 Dec 2025	10-K	27 Feb 2026	2025	FY
2024	$8,419,000	+$3,067,000	+57%	01 Jan 2024	31 Dec 2024	10-K	27 Feb 2026	2025	FY
2023	$5,352,000	+$3,219,000	+151%	01 Jan 2023	31 Dec 2023	10-K	27 Feb 2026	2025	FY
2022	$2,133,000	+$1,448,000	+211%	01 Jan 2022	31 Dec 2022	10-K	27 Feb 2025	2024	FY
2021	$685,000	-$525,000	-43%	01 Jan 2021	31 Dec 2021	10-K	27 Feb 2024	2023	FY
2020	$1,210,000	+$417,000	+53%	01 Jan 2020	31 Dec 2020	10-K	08 Mar 2023	2022	FY
2019	$793,000			01 Jan 2019	31 Dec 2019	10-K	04 Mar 2022	2021	FY

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025		$2,461,000	+$552,000	+29%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q1 2024		$1,909,000	+$985,000	+107%	01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q2 2023	$3,423,000	$1,100,000	+$700,000	+175%	01 Apr 2023	30 Jun 2023	10-Q	09 Aug 2023	2023	Q2
Q1 2023	$2,723,000	$924,000	+$590,000	+177%	01 Jan 2023	31 Mar 2023	10-Q	07 May 2024	2024	Q1
Q4 2022	$2,133,000	$999,000	+$731,000	+273%	01 Oct 2022	31 Dec 2022	10-K	27 Feb 2025	2024	FY
Q3 2022	$1,402,000	$400,000	+$200,000	+100%	01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022	$1,202,000	$400,000	+$300,000	+300%	01 Apr 2022	30 Jun 2022	10-Q	09 Aug 2023	2023	Q2
Q1 2022	$902,000	$334,000	+$217,000	+185%	01 Jan 2022	31 Mar 2022	10-Q	09 May 2023	2023	Q1
Q4 2021	$685,000	$268,000	+$62,000	+30%	01 Oct 2021	31 Dec 2021	10-K	27 Feb 2024	2023	FY
Q3 2021	$623,000	$200,000	-$100,000	-33%	01 Jul 2021	30 Sep 2021	10-Q	09 Nov 2022	2022	Q3
Q2 2021	$723,000	$100,000	-$300,000	-75%	01 Apr 2021	30 Jun 2021	10-Q	10 Aug 2022	2022	Q2
Q1 2021	$1,023,000	$117,000	-$187,000	-62%	01 Jan 2021	31 Mar 2021	10-Q	06 May 2022	2022	Q1
Q4 2020	$1,210,000	$206,000			01 Oct 2020	31 Dec 2020	10-K	08 Mar 2023	2022	FY
Q3 2020		$300,000			01 Jul 2020	30 Sep 2020	10-Q	04 Nov 2021	2021	Q3
Q2 2020		$400,000			01 Apr 2020	30 Jun 2020	10-Q	05 Aug 2021	2021	Q2
Q1 2020		$304,000			01 Jan 2020	31 Mar 2020	10-Q	25 May 2021	2021	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.